A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women

Maturitas

Volumn 53, Issue 1, 2006, Pages 32-38

  Kurtay, Gulay ^a   Ozmen, Batuhan ^a   Erguder, Imge ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Estradiol hemi hydrate; HRT; Nitric oxide; Norethisterone acetate

Indexed keywords

ESTRADIOL; NITRIC OXIDE; NORETHISTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; DIET; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; SERUM; SMOKING; TISSUE LEVEL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE; NORETHINDRONE; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 28444492005     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.02.004     Document Type: Article

References (30)

1. R. Busse, and I. Fleming Endothelial dysfunction in atherosclerosis J Vasc Res 33 1996 181 194
2. J. Loscalzo, and G. Welch Nitric oxide and its role in the cardiovascular system Prog Cardiovasc Dis 38 1995 87 104
3. V. Gisclard, V.M. Miller, and P.M. Vanhoutte Effect of 17b-estradiol on endothelium-dependent responses in the rabbit J Pharmacol Exp Ther 244 1988 19 22
4. A. Lerman, D.R. Holmes Jr., and M.R. Bell Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans Circulation 92 1995 2426 2431
5. S.P. Duckles, D.N. Krause, and V.M. Miller Effects of gonadal steroids on vascular function J Pharmacol Exp Ther 279 1996 1 3
6. E.H. Lieberman, M.D. Gerhard, and A. Uehata Estrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women Ann Intern Med 121 1994 936 941
7. S.E. Akhan, T. Gurel, and R. Has Effects of long-term oral hormone replacement therapy on serum nitric oxide and beta-endorphin levels in postmenopausal women Gynecol Obstet Invest 54 4 2002 196 200
8. G. Christodoulakos, C. Panoulis, and E. Kouskouni Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis Gynecol Endocrinol 16 1 2002 9 17
9. I.S. Serin, E.M. Aygen, and M. Basbug Continuous versus cyclical transdermal oestrogen replacement therapy in postmenopausal women: effects on lipoprotein(a) and nitric oxide levels Aust N Z J Obstet Gynaecol 41 4 2001 447 449
10. A. Lai, J. Zhang, and L. Ding Changes of nitric oxide and endothelin serum levels and effects of hormone replacement therapy in postmenopausal women Zhonghua Fu Chan Ke Za Zhi 35 4 2000 222 224
11. A. Saitta, D. Altavilla, and D. Cucinotta Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on serum no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women Arterioscler Thromb Vasc Biol 21 9 2001 1512 1519
12. D.M. Gilligan, D.M. Badar, and J.A. Panza Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women Am J Cardiol 75 1995 264 268
13. K. Sudhir, G.L. Jennings, and J.W. Funder Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women Hypertension 28 1996 330 334
14. A. Cagnacci, R. Tarquini, and F. Perfetto Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women: a cross-sectional and a randomized cross-over study Maturitas 44 2 2003 117 124
15. B. Imthurn, and Marinella Rosselli Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17b-estradiol valerate and cyprotereone acetate or medroxyprogesterone acetate J Clin Endocrinol Metab 82 1997 383 419
16. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
17. M. Rosselli, B. Imthurn, and E. Macas Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO-release Biochem Biophys Res Commun 202 1994 1543 1552
18. M. Rosselli, B. Imthurn, and P.J. Keller Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17b-estradiol and norethisterone acetate: a two year follow-up study Hypertension 25 1995 848 853
19. M.J. Stampfer, G.A. Colditz, and W.C. Willett Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study N Engl J Med 325 1991 756 762
20. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 380 1998 605 613
21. P. Collins, G.M. Rosano, P.M. Sarrel, and L. Ulrich 17Beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease Circulation 92 1995 24 30
22. R.A. Lobo The role of progestins in hormone replacement therapy Am J Obstet Gynecol 166 1992 1997 2004
23. A.A. Nabulsi, A.R. Folsom, and A. White Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women N Engl J Med 328 1993 1069 1075
24. P.J.M. Best, P.B. Berger, and V.M. Miller The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women Ann Intern Med 128 4 1998 285 288
25. K. Hishikawa, T. Nakaki, and T. Marumo Induction of constitutive nitric oxide synthase by estradiol in human endothelial cells Hypertension 24 1994 386 (Abstract 83)
26. G.A. Van-Buren, D.S. Yang, and K.E. Clark Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis Am J Obstet Gynecol 167 1992 828 833
27. M.N. Sack, D.J. Rader, and R.O. Cannon Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women Lancet 343 1994 269 270
28. D.W. Losordo, M. Kearney, and E.A. Kim Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women Circulation 89 1994 1501 1510
29. M.W. Radomnski, R.M.J. Palmer, and S. Moncada Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells Proc Natl Acad Sci USA 87 1990 10043 10047
30. O. Ylikorkala, B. Cacciatore, and I. Paakkari The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane Fertil Steril 69 5 1998 883 888